Jhunjhunwala family-backed IKS Health acquires U.S. health-tech firm for ₹1,600 cr; plans IPO by Q4 FY24
The company will fund the acquisition by raising ₹1,000 crore from three global banks, and the remaining ₹600 crore from internal accruals.
The company will fund the acquisition by raising ₹1,000 crore from three global banks, and the remaining ₹600 crore from internal accruals.